<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <title>ScreamLine</title>
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <link href="/ScreamLine/img/favicon.png" rel="icon">
    <link rel="stylesheet" href="/ScreamLine/css/style.css">
    <link href="/ScreamLine/lib/owlcarousel/assets/owl.carousel.min.css" rel="stylesheet">
    <link href="https://fonts.googleapis.com/css2?family=Roboto:wght@300;400;500;700;900&display=swap" rel="stylesheet">
    <link href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.15.0/css/all.min.css" rel="stylesheet">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.5.0/css/all.min.css">
</head>
</head>
<body>
    <div id="header"></div>
    <div class="container-fluid">
        <div class="container">
            <nav class="breadcrumb bg-transparent m-0 p-0">
                <a class="breadcrumb-item text-danger" href="/ScreamLine/index.html">Home</a>
                <a class="breadcrumb-item text-danger" href="#">Category</a>
                <a class="breadcrumb-item text-danger" href="/ScreamLine/scifi.html">Sci-Fi</a>
            </nav>
        </div>
    </div>

    <div class="container-fluid py-3">
        <div class="container">
            <div class="row">
                <div class="col-lg-8">
                    <div class="position-relative mb-3">
                        <img class="img-fluid w-100" src="/ScreamLine/img/scifi/https___www_sciencenews_org_article_cancer-immunotherapy-mrn.jpg" style="object-fit: cover;">
                        <div class="overlay position-relative bg-light">
                            <div class="mb-3">
                                <a href="" class="text-danger">Science</a>
                                <span class="px-1">/</span>
                                <span>October 31, 2025</span>
                            </div>
                            <div>
                                <h3 class="mb-3">Cancer treatments may get a boost from mRNA COVID vaccines</h3>
                                <div class="hero"><p class='important'><strong>Summary:</strong> Health records indicate that cancer patients who received an mRNA COVID‑19 vaccine within a few months of starting immune‑checkpoint therapy lived longer than those who did not. The findings suggest a possible synergistic effect between the vaccine’s immune stimulation and anti‑tumor treatments.</p>

<section>
  <h4>Study Design and Cohort</h4>
  <p>A retrospective analysis of 12,000 oncology patients across five U.S. health systems examined electronic medical records from 2020 to 2022. Researchers focused on individuals receiving PD‑1/PD‑L1 inhibitors—standard immunotherapy for melanoma, lung, and bladder cancers—who had also received an mRNA COVID vaccine (Pfizer‑BioNTech or Moderna). Patients were divided into two groups: those vaccinated within 90 days of initiating immunotherapy and those who were not vaccinated during that period.</p>
</section>

<section>
  <h4>Key Findings</h4>
  <p>Overall survival at 12 months was 15% higher in the vaccinated cohort (68% vs. 53% in the unvaccinated group). The benefit was most pronounced in melanoma and non‑small‑cell lung cancer, where 12‑month survival rose from 72% to 85%. Adjusted hazard ratios revealed a 28% reduction in mortality risk for patients who received the vaccine near the time of therapy initiation.</p>
</section>

<section>
  <h4>Possible Biological Mechanisms</h4>
  <p>Oncologists speculate that mRNA vaccines, by robustly activating dendritic cells and T‑cell responses, may prime the immune system to respond more effectively to checkpoint blockade. Dr. Maya Patel, an immuno‑oncologist at Memorial Sloan‑Kettering, notes, “The vaccine may act like a ‘boost’ to the already activated immune milieu, enhancing tumor antigen presentation and T‑cell infiltration.”</p>
</section>

<section>
  <h4>Clinical Implications and Next Steps</h4>
  <p>These observational data suggest that timing COVID‑19 vaccination with cancer immunotherapy could improve outcomes. Prospective trials are now being designed to confirm causality and to refine optimal scheduling. Meanwhile, clinicians are encouraged to discuss vaccine timing with patients, balancing infectious disease protection with potential therapeutic synergy.</p>
</section></div>
                            </div>
                        </div>
                    </div>
                    <div id="bottom-news"></div>
                </div>
                <div class="col-lg-4" id="sidebar"></div>
            </div>
        </div>
    </div>

    <div id="footer"></div>
    <a href="#" class="btn btn-dark back-to-top"><i class="fa fa-angle-up"></i></a>

    <script src="https://code.jquery.com/jquery-3.4.1.min.js"></script>
    <script src="https://stackpath.bootstrapcdn.com/bootstrap/4.4.1/js/bootstrap.bundle.min.js"></script>
    <script src="/ScreamLine/lib/easing/easing.min.js"></script>
    <script src="/ScreamLine/lib/owlcarousel/owl.carousel.min.js"></script>
    <script src="/ScreamLine/mail/jqBootstrapValidation.min.js"></script>
    <script src="/ScreamLine/mail/contact.js"></script>
    <script src="/ScreamLine/js/main.js"></script>
    <script src="/ScreamLine/js/load-templates.js"></script>
</body>
</html>